IBDEI0NS ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,11104,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11104,1,3,0)
 ;;=3^Diabetes Type 2 w/ Diabetic Reinopathy w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,11104,1,4,0)
 ;;=4^E11.319
 ;;^UTILITY(U,$J,358.3,11104,2)
 ;;=^5002633
 ;;^UTILITY(U,$J,358.3,11105,0)
 ;;=Z72.4^^47^527^30
 ;;^UTILITY(U,$J,358.3,11105,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11105,1,3,0)
 ;;=3^Diet & Eating Habits,Inappropriate
 ;;^UTILITY(U,$J,358.3,11105,1,4,0)
 ;;=4^Z72.4
 ;;^UTILITY(U,$J,358.3,11105,2)
 ;;=^5063257
 ;;^UTILITY(U,$J,358.3,11106,0)
 ;;=R68.81^^47^527^31
 ;;^UTILITY(U,$J,358.3,11106,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11106,1,3,0)
 ;;=3^Early Satiety
 ;;^UTILITY(U,$J,358.3,11106,1,4,0)
 ;;=4^R68.81
 ;;^UTILITY(U,$J,358.3,11106,2)
 ;;=^5019554
 ;;^UTILITY(U,$J,358.3,11107,0)
 ;;=E34.9^^47^527^32
 ;;^UTILITY(U,$J,358.3,11107,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11107,1,3,0)
 ;;=3^Endocrine Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,11107,1,4,0)
 ;;=4^E34.9
 ;;^UTILITY(U,$J,358.3,11107,2)
 ;;=^5002777
 ;;^UTILITY(U,$J,358.3,11108,0)
 ;;=R62.7^^47^527^33
 ;;^UTILITY(U,$J,358.3,11108,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11108,1,3,0)
 ;;=3^Failure to Thrive,Adult
 ;;^UTILITY(U,$J,358.3,11108,1,4,0)
 ;;=4^R62.7
 ;;^UTILITY(U,$J,358.3,11108,2)
 ;;=^322019
 ;;^UTILITY(U,$J,358.3,11109,0)
 ;;=R63.3^^47^527^34
 ;;^UTILITY(U,$J,358.3,11109,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11109,1,3,0)
 ;;=3^Feeding Difficulty
 ;;^UTILITY(U,$J,358.3,11109,1,4,0)
 ;;=4^R63.3
 ;;^UTILITY(U,$J,358.3,11109,2)
 ;;=^5019541
 ;;^UTILITY(U,$J,358.3,11110,0)
 ;;=E87.8^^47^527^35
 ;;^UTILITY(U,$J,358.3,11110,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11110,1,3,0)
 ;;=3^Fluid & Electrolyte Balance Disorder NEC
 ;;^UTILITY(U,$J,358.3,11110,1,4,0)
 ;;=4^E87.8
 ;;^UTILITY(U,$J,358.3,11110,2)
 ;;=^5003026
 ;;^UTILITY(U,$J,358.3,11111,0)
 ;;=E87.70^^47^527^36
 ;;^UTILITY(U,$J,358.3,11111,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11111,1,3,0)
 ;;=3^Fluid Overload,Unspec
 ;;^UTILITY(U,$J,358.3,11111,1,4,0)
 ;;=4^E87.70
 ;;^UTILITY(U,$J,358.3,11111,2)
 ;;=^5003023
 ;;^UTILITY(U,$J,358.3,11112,0)
 ;;=R73.01^^47^527^50
 ;;^UTILITY(U,$J,358.3,11112,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11112,1,3,0)
 ;;=3^Impaired Fasting Glucose
 ;;^UTILITY(U,$J,358.3,11112,1,4,0)
 ;;=4^R73.01
 ;;^UTILITY(U,$J,358.3,11112,2)
 ;;=^5019561
 ;;^UTILITY(U,$J,358.3,11113,0)
 ;;=R73.02^^47^527^51
 ;;^UTILITY(U,$J,358.3,11113,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11113,1,3,0)
 ;;=3^Impaired Oral Glucose Tolerance
 ;;^UTILITY(U,$J,358.3,11113,1,4,0)
 ;;=4^R73.02
 ;;^UTILITY(U,$J,358.3,11113,2)
 ;;=^5019562
 ;;^UTILITY(U,$J,358.3,11114,0)
 ;;=E83.119^^47^527^37
 ;;^UTILITY(U,$J,358.3,11114,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11114,1,3,0)
 ;;=3^Hemochromatosis,Unspec
 ;;^UTILITY(U,$J,358.3,11114,1,4,0)
 ;;=4^E83.119
 ;;^UTILITY(U,$J,358.3,11114,2)
 ;;=^5002995
 ;;^UTILITY(U,$J,358.3,11115,0)
 ;;=E83.52^^47^527^38
 ;;^UTILITY(U,$J,358.3,11115,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11115,1,3,0)
 ;;=3^Hypercalcemia
 ;;^UTILITY(U,$J,358.3,11115,1,4,0)
 ;;=4^E83.52
 ;;^UTILITY(U,$J,358.3,11115,2)
 ;;=^59932
 ;;^UTILITY(U,$J,358.3,11116,0)
 ;;=E11.65^^47^527^22
 ;;^UTILITY(U,$J,358.3,11116,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11116,1,3,0)
 ;;=3^Diabetes Type 2 w/ Hyperglycemia
 ;;^UTILITY(U,$J,358.3,11116,1,4,0)
 ;;=4^E11.65
 ;;^UTILITY(U,$J,358.3,11116,2)
 ;;=^5002663
 ;;^UTILITY(U,$J,358.3,11117,0)
 ;;=R73.9^^47^527^39
 ;;^UTILITY(U,$J,358.3,11117,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11117,1,3,0)
 ;;=3^Hyperglycemia,Unspec
